Kellett Wealth Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$373K Buy
2,903
+81
+3% +$9.48K 0.17% 62
2026
Q1
$339K Buy
2,822
+313
+12% +$36.1K 0.18% 57
2025
Q4
$264K Sell
2,509
-307
-11% -$28.8K 0.15% 63
2025
Q3
$236K Sell
2,816
-55
-2% -$4.53K 0.14% 67
2025
Q2
$227K Buy
2,871
+381
+15% +$30.3K 0.15% 63
2025
Q1
$224K Hold
2,490
0.15% 64
2024
Q4
$248K Sell
2,490
-212
-8% -$21.9K 0.17% 56
2024
Q3
$307K Buy
2,702
+1
+0% +$119 0.22% 55
2024
Q2
$334K Buy
2,701
+1
+0% +$129 0.27% 43
2024
Q1
$356K Buy
2,700
+2
+0.1% +$247 0.25% 52
2023
Q4
$294K Buy
2,698
+1
+0% +$104 0.22% 60
2023
Q3
$278K Buy
2,697
+1
+0% +$108 0.24% 49
2023
Q2
$311K Buy
+2,696
New +$306K 0.28% 37

Other funds holding MRK

Kellett Wealth Advisors's MRK Position: Q2 2026 in Review

Kellett Wealth Advisors increased its Merck (MRK) stake by 2.9% in Q2 2026, buying an estimated $9.48K and bringing the position to 2,903 shares worth $373K. The position accounts for 0.17% of the portfolio, ranked #62.

Kellett Wealth Advisors first reported a position in MRK in Q2 2023 and has held it in 13 quarters since. 1,411 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Kellett Wealth Advisors held 2,903 shares of Merck worth $373K as of Q2 2026.
  • Kellett Wealth Advisors bought 81 Merck shares in Q2 2026, an estimated $9.48K.
  • Merck made up 0.17% of Kellett Wealth Advisors's portfolio in Q2 2026, its #62 holding.
  • Kellett Wealth Advisors first reported a position in Merck in Q2 2023 and has held it in 13 quarters since.
  • 1,411 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Kellett Wealth Advisors's 13F filing for Q2 2026, filed 23 Jul 2026.